Preclinical
CN045 promoted human OPC differentiation and remyelination in mice
An npj Drug Discovery paper described CN045, a CNS-penetrant lead that promoted OPC differentiation and myelin-like ensheathment in human cells in vitro and increased remyelination in a mouse demyelination model.
Practical availability: Preclinical — not available as a clinical intervention
What this means clinically
This is an interesting drug-development lead, but it remains preclinical. Pharmacokinetic optimisation, toxicology and then human testing are still required.
Source quality: High for a preclinical finding • peer-reviewed primary paper
Peer-reviewed papernpj Drug Discovery ↗